#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3198	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1895	288.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1345	1345	C	362	C	221	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3198	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1895	288.9	0	HET	.	.	.	A69G	.	69	69	A	230	230	A	234	A,G	64,79	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5238	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3424	260.9	0	.	n	.	0	T695C	SNP	695	695	T	900	900	C	334	C	203	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5238	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3424	260.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1542	1542	A	238	A,G	146,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5238	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3424	260.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2176	2176	C	282	C	169	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5238	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3424	260.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2802	2802	T	316	T,C	96,99	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5238	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3424	260.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2250	2250	A	334	A	200	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	783	356	folP	855	172	94.22	folP.l6.c30.ctg.1	496	0.4	0	.	p	.	0	L26R	NONSYN	76	78	CTC	18	20	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	783	356	folP	855	172	94.22	folP.l6.c30.ctg.1	496	0.4	0	.	p	.	0	S30C	NONSYN	88	90	TCT	6	8	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	783	356	folP	855	172	94.22	folP.l6.c30.ctg.1	496	0.4	0	.	p	.	0	Q42P	NONSYN	124	126	CAA	415	417	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	783	356	folP	855	172	94.22	folP.l6.c30.ctg.1	496	0.4	0	.	p	.	0	A46fs	FSHIFT	136	136	G	427	427	G	ND	ND	ND	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	783	356	folP	855	855	100.0	folP.l6.c30.ctg.2	1602	38.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1023	1025	AGC	59;59;59	A;G;C	37;38;36	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	906	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3209	47.9	1	SNP	p	S91F	1	.	.	271	273	TTC	545	547	TTC	62;62;60	T;T;C	36;35;34	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	906	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3209	47.9	1	SNP	p	G95N	0	.	.	283	285	GGC	557	559	GGC	73;71;71	G;G;C	43;41;42	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	906	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3209	47.9	1	SNP	p	D95G	1	.	.	283	285	GGC	557	559	GGC	73;71;71	G;G;C	43;41;42	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	15	198	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1010	30.3	1	SNP	p	G45D	0	.	.	133	135	GGC	290	292	GGC	49;49;49	G;G;C	26;28;28	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	15	198	mtrR	633	92	100.0	mtrR.l6.c4.ctg.2	739	7.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	178	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	583	49.8	0	.	n	.	0	A197.	DEL	197	197	A	312	312	A	80	A	51	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	44.3	1	SNP	p	D86N	0	.	.	256	258	GAC	591	593	GAC	54;54;57	G;A;C	34;34;37	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	44.3	1	SNP	p	S87R	1	.	.	259	261	CGT	594	596	CGT	57;58;59	C;G;T	37;38;36	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	44.3	1	SNP	p	R87I	0	.	.	259	261	CGT	594	596	CGT	57;58;59	C;G;T	37;38;36	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	44.3	1	SNP	p	R87W	0	.	.	259	261	CGT	594	596	CGT	57;58;59	C;G;T	37;38;36	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	44.3	1	SNP	p	S88P	0	.	.	262	264	TCC	597	599	TCC	59;59;56	T;C;C	39;39;39	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	700	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2743	43.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1582	1584	GGC	38;38;38	G;G;C	24;24;24	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1198	1200	GCA	78;80;80	G;C;A	46;48;51	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1201	1203	ATC	80;80;80	A;T;C	50;49;50	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1213	1215	GTG	83;83;83	G;T;G	49;46;50	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1213	1215	GTG	83;83;83	G;T;G	49;46;50	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1717	1719	ACC	67;68;67	A;C;C,G	38;42;41,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1771	1773	GCG	53;52;54	G;C;G	32;29;31	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1771	1773	GCG	53;52;54	G;C;G	32;29;31	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1894	1896	AGC	37;36;39	A;G;C	24;23;26	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1903	1905	GGC	38;38;35	G;G;C	26;26;24	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	776	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2202	60.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1921	1923	CCG	38;37;37	C;C;G	22;21;21	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1118	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3240	56.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1524	1526	CCG	41;41;41	C;C;G	27;30;26	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	334	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1715	32.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	601	601	C	34	C	18	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	366	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2061	31.6	0	.	p	.	0	E48K	NONSYN	142	144	GAA	858	860	AAA	54;54;54	A;A;A	30;32;32	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	366	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2061	31.6	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1347	1347	T	41	T	24	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	366	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2061	31.6	1	SNP	p	G120K	0	.	.	358	360	GGT	1074	1076	GGT	41;41;42	G;G;T	25;23;23	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	366	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2061	31.6	1	SNP	p	A121N	0	.	.	361	363	GCC	1077	1079	GCC	42;42;42	G;C;C	23;25;25	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	366	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2061	31.6	1	SNP	p	A121D	0	.	.	361	363	GCC	1077	1079	GCC	42;42;42	G;C;C	23;25;25	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1734	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4789	63.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	138	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	873	30.5	1	SNP	p	V57M	1	.	.	169	171	ATG	479	481	ATG	40;41;41	A;T;G	28;29;29	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
